V. Ya. Sosnovskikh et al. / Tetrahedron Letters 45 (2004) 7351–7354
7353
the conformation in which the amide carbonyl is situ-
ated near H-3 and deshields this atom.
Acknowledgements
This work was financially supported by the Russian
Foundation for Basic Research (Grant 02-03-32706)
and by the U.S. Civilian Research and Development
Foundation and Russian Federation Ministry of Educa-
tion (Grants EK-005-X1 and Y1-005-04).
Further transformations are also possible for a,b-enoxi-
mes 3. Nitrosation of these compounds using NaNO2 in
dilute HCl afforded oximinoisoxazolines 5a,b in 78%
and 59% yields, respectively. Formation of 5 from 3
may occur via electrophilic attack at the a-position of
3 by the nitrosonium cation. The resulting cationic spe-
cies then undergoes nucleophilic attack by the hydroxyl
group to give the 4-nitrosoisoxazoline which exists in the
oxime form. Nitrosation of a,b-unsaturated oximes with
nitrous acid has been described previously, however, the
products were 3,5,5-trimethylpyrazolenine 1,2-dioxide
(from mesityl oxide oxime),18 3,4-diazacyclopentadi-
enone 3,4-dioxides (from b-alkyl or aryl a,b-unsaturated
oximes),19 and 1-hydroxypyrazole 2-oxides (from a-substi-
tuted a,b-unsaturated oximes),20 which arise from initial
attack at the oxime nitrogen atom by the nitrosonium
cation. Bromination of oximes 3a,b was accomplished
in CCl4 with bromine at room temperature. The reaction
was rapid and gave 4-bromoisoxazolines 6a,b as a mix-
ture of two diastereomers in 89–92% yields (92:8 for 6a
and 96:4for 6b). The relative ease with which electrophi-
lic attack towards the a-C atom of the exo-double bond
occurs may be due to the intermediate benzopyrylium
cation A and the neighboring-group participation of
the oxime hydroxyl group, which is syn to the C@C
bond.
References and notes
1. Ellis, G. P. Chromenes, Chromanones, and Chromones.
In The Chemistry of Heterocyclic Compounds; Wiley: New
York, 1977; Vol. 31.
2. De Meyer, N.; Haemers, A.; Mishra, L.; Pandey, H.-K.;
Pieters, L. A. C.; Van den Berghe, D. A.; Vlietinck, A. J.
J. Med. Chem. 1991, 34, 736–746.
3. (a) Nohara, A.; Kuriki, H.; Saijo, T.; Ukawa, K.; Murata,
T.; Kanno, M.; Sanno, Y. J. Med. Chem. 1975, 18, 34–37;
(b) Nohara, A.; Kuriki, H.; Saijo, T.; Sugihara, H.;
Kanno, M.; Sanno, Y. J. Med. Chem. 1977, 20, 141–145;
(c) Ellis, G. P.; Becket, G. J. P.; Shaw, D.; Wilson, N. K.;
Vardey, C. J.; Skidmore, I. F. J. Med. Chem. 1978, 21,
1120–1126.
4. Bolos, J.; Gubert, S.; Anglada, L.; Planas, J. M.; Burgar-
´
olas, C.; Castello, J. M.; Sacristan, A.; Ortiz, J. A. J. Med.
Chem. 1996, 39, 2962–2970.
5. (a) Sosnovskikh, V. Ya. Uspekhi Khimii 2003, 72, 550–578,
(Russ. Chem. Rev. 2003, 72, 489–516); (b) Ghosh, C. K. J.
Heterocycl. Chem. 1983, 20, 1437–1445; (c) Morin, C.;
Beugelmans, R. Tetrahedron 1977, 33, 3183–3192.
6. (a) Sosnovskikh, V. Ya.; Sevenard, D. V.; Usachev, B. I.;
Ro¨schenthaler, G.-V. Tetrahedron Lett. 2003, 44,
2097–2099; (b) Sosnovskikh, V. Ya.; Usachev, B. I.;
Sevenard, D. V.; Ro¨schenthaler, G.-V. J. Org. Chem.
2003, 68, 7747–7754; (c) Sevenard, D. V.; Sosnovskikh, V.
Ya.; Kolomeitsev, A. A.; Ko¨nigsmann, M. H.; Ro¨schent-
haler, G.-V. Tetrahedron Lett. 2003, 44, 7623–7627.
7. Sosnovskikh, V. Ya.; Usachev, B. I. Izv. Akad. Nauk, Ser.
Khim., in press (Russ. Chem. Bull., Int. Ed., 2004, 53, in press).
8. (a) Beam, C. F.; Dyer, M. C. D.; Schwarz, R. A.; Hauser,
C. R. J. Org. Chem. 1970, 35, 1806–1810; (b) Fulmer, T.
D.; Dasher, L. P.; Bobb, B. L.; Wilson, J. D.; Sides, K. L.;
Beam, C. F. J. Heterocycl. Chem. 1980, 17, 799–800;
(c) Livingston, M. J.; Chick, M. F.; Shealy, E. O.; Beam,
C. F. J. Heterocycl. Chem. 1982, 19, 215–217; (d) He, Y.;
Lin, N.-H. Synthesis, 1994, 989–992.
9. (a) Barber, G. N.; Olofson, R. A. J. Org. Chem. 1978, 43,
3015–3021; (b) Hoskin, D. H.; Olofson, R. A. J. Org.
Chem. 1982, 47, 5222–5225; (c) Nitz, T. J.; Volkots, D. L.;
Aldous, D. J.; Oglesby, R. C. J. Org. Chem. 1994, 59,
5828–5832.
10. (a) Walters, M. J.; Dunn, S. P.; Choi, E.; DÕElia, A. N.;
Warner, M. E.; Beam, C. F. Synth. Commun. 2003, 33,
4163–4171; (b) Townsend, J. D.; Kelley, W., Jr.; Rose, K.
L.; Schady, D. A.; Downs, J. R.; Greer, H. A.; Pastine, S.
J.; Beam, C. F. Synth. Commun. 2000, 30, 2175–2189.
11. Fox, B. L.; Reboulet, J. E. J. Org. Chem. 1970, 35,
4234–4236.
Finally, in attempting to ascertain if related chromones
can participate in this reaction, we found that 2-methyl-
chromone reacts with acetophenone oxime in the
presence of lithium diisopropylamide to give the corre-
sponding spiroisoxazoline 2e in a remarkable 97% yield,
in spite of the known susceptibility of the 2-methyl
group to deprotonation by basic reagents.21 Flavone
was similarly converted in 65% yield to compound 2f.
However, in the case of chromone, the reaction mix-
ture almost immediately becomes dark-red and resinifies
under the same conditions, since the absence of a
substituent allows the base relatively free access to the
2-position and consequently to nucleophilic attack and
other ring-opening reactions.22 (Scheme 3).
In summary, we have developed a simple and practical
access to 4H-chromene-4-spiro-50-isoxazolines, which
can be easily converted to other chromone derivatives
possessing a variety of functionalities. Further studies
on the synthetic application of spiroannulated isoxazo-
lines are now in progress.
Ph
12. 2-(Trifluoromethyl)-4H-chromene-4-spiro-50-30-phenyl- 40,
50-dihydroisoxazole (2a). Yield 83%, mp 124–125°C,
colorless needles; (Found: C, 65.18; H, 3.43; N, 4.20.
C18H12F3NO2 requires C, 65.26; H, 3.65; N, 4.23%); mmax
(Nujol) 1695 (C@C), 1615, 1595, 1585 (arom.) cmÀ1; d
(400MHz, CDCl3) 3.57 (1H, d, J = 17.5Hz, CHH), 3.78
(1H, d, J = 17.5Hz, CHH), 5.95 (1H, s, @CH), 7.18 (1H,
dd, oJ = 8.4Hz, mJ = 1.1Hz, H-8), 7.24(1H, ddd, oJ = 7.9,
N
O
O
Me
HO
Ph
1) Pri2NLi
2) H3O+
+
N
O
R
O
R
2e,f
R = Me (e), Ph (f)
Scheme 3.
o
7.3Hz, mJ = 1.1Hz, H-6), 7.39 (1H, ddd, J = 8.4, 7.3Hz,